Chemours Valuation
| 0HWG Stock | 20.05 1.00 4.75% |
At this time, the firm appears to be fairly valued. Chemours shows a prevailing Real Value of USD20.68 per share. The current price of the firm is USD20.05. Our model approximates the value of Chemours from analyzing the firm fundamentals such as return on equity of 0.11, and Profit Margin of 0.01 % as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 6.9 B | Price Sales 0.616 | Trailing PE 0.0473 |
Fairly Valued
Today
Please note that Chemours' price fluctuation is not too volatile at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Chemours stock is determined by what a typical buyer is willing to pay for full or partial control of Chemours Co. Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.05 | Real 20.68 | Hype 21.69 | Naive 20.7 |
The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chemours' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Chemours Co helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors: Chemours Cash |
|
Chemours Total Value Analysis
Chemours Co is presently projected to have takeover price of 6.89 B with market capitalization of 354.13 B, debt of 4.23 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chemours fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.89 B | 354.13 B | 4.23 B |
Chemours Investor Information
About 83.0% of the company shares are owned by institutions such as pension funds. The company had not issued any dividends in recent years. Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, Chemours Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 589 M | 556 M |
|
| |||||
| Operating Income | 571 M | 673 M |
|
|
Chemours Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemours has an asset utilization ratio of 73.05 percent. This implies that the Company is making USD0.73 for each dollar of assets. An increasing asset utilization means that Chemours Co is more efficient with each dollar of assets it utilizes for everyday operations.Chemours Ownership Allocation
Chemours holds a total of 171.08 Million outstanding shares. The majority of Chemours Co outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Co as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chemours Profitability Analysis
The company reported the revenue of 6.03 B. Net Loss for the year was (238 M) with profit before overhead, payroll, taxes, and interest of 1.62 B.About Chemours Valuation
The stock valuation mechanism determines Chemours' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Chemours based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chemours. We calculate exposure to Chemours's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemours's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.3 B | 1.2 B |
Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.